Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun(Peking University), Cen Xie(National Institutes of Health), Guang Wang(Capital Medical University), Yue Wu(First Affiliated Hospital of Xi'an Jiaotong University), Qing Wu(Peking University), Xuemei Wang(Peking University), Jia Liu(Capital Medical University), Yangyang Deng(First Affiliated Hospital of Xi'an Jiaotong University), Jialin Xia(Peking University), Bo Chen(Peking University), Song‐Yang Zhang(Peking University), Chuyu Yun(Peking University), Guan Lian(Peking University), Xiujuan Zhang(Peking University), Heng Zhang(Capital Medical University), William H. Bisson(Oregon State University), Jing-Min Shi(National Institutes of Health), Xiaoxia Gao(National Institutes of Health), Pupu Ge(Chinese Academy of Sciences), Cuihua Liu(Chinese Academy of Sciences), Kristopher W. Krausz(National Institutes of Health), Robert G. Nichols(Pennsylvania State University), Jingwei Cai(Pennsylvania State University), Bipin Rimal(Pennsylvania State University), Andrew D. Patterson(Pennsylvania State University), Xian Wang(Peking University), Frank J. Gonzalez(National Institutes of Health), Changtao Jiang(Peking University)
Cited by 1,002Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis